Abbonarsi
Per ulteriori informazioni
Questo prodotto esiste ed è attivo ma non è nella lingua scelta in questo momento
couverture
Current Research in Translational Medicine

.

EDITOR-IN-CHIEF
Prof. I. Yakoub-Agha, Dept. of Haematology, Head of the Immune Cellular Therapy Unit, Lille University Hospital, Lille, France


EDITORS

Dr T. Alsuliman, Dept. of Haematology and cellular therapy, Saint-Antoine hospital, APHP, Paris ; Sorbonne University, Paris, France

Prof. M. Beksac, Dept. of Hematology, Ankara University, Ankara, Turkey
Prof. H. Bönig, Dept of Translational Development of Cellular Therapeutics, Institute for Transfusion Medicine and Immune Hematology, Johann-Wolfgang-Goethe Medical University, Frankfurt, Germany
Dr E. Brissot, Dept. of Haematology and cellular therapy, Saint-Antoine hospital, APHP, Paris ; Sorbonne University, Paris, France
Prof. G. Damaj, Dept. of Haematology, Caen University Hospital, Caen, France

Dr J. Demaret, Lille University Hospital, Lille, France

Dr R. Greco, Blood and Marrow Transplant Unit (BMT), San Raffaele Scientific Hospital (IRCCS), Milano, Italy
Prof. M. Guzman, Weill Cornell Medicine, New York, USA
Dr P. Hayden, St. James's hospital, Dublin, Ireland
Dr D. Humaidan, Eberhard Karls University of Tuebingen and Max Planck International Research School for Intelligent Systems (IMPRS-IS), Tuebingen, Germany
Prof. M. Ahmad Kassab, Research Associate, University of Pennsylvanian, Philadelphia, Pennsylvania, USA
Prof. M. Labalette, Lab of Immunology and HLA, Lille University Hospital, Lille, France
Prof. J. Larghero, Saint Louis Hospital, Paris, France
Prof. J. J. Melenhorst, University of Pennsylvania, Philadelphia, United States

Dr C. Roddie, University of London, London, UK
Prof. J. A Snowden, Consultant Haematologist & Director of Blood and Marrow Transplantation, Sheffi eld Teaching Hospitals NHS Foundation Trust Sheffi eld, UK

Prof. M. Subklewe, LMU University Hospital Munich, Munich, Germany

Dr A. Sureda, Blood Cell Barcelona Hematology Institute, Barcelona, Spain

.

BIOSTATISTICIAN

Dr M. Ordak, Centre for Preclinical, Research and Technology (CePT), Medical University of Warsaw, Poland

.

INTERNATIONAL SCIENTIFIC COMMITTEE

R. Burt (Northwestern University Feinberg School of Medicine, Chicago, United States), F. Calvo (INSERM U749, Villejuif, France), O. Cohen Haguenauer (University Institute of Geriatry of Sherbrooke, Paris, France), T. Fülop (Sherbrooke University of Applied Sciences Institute, Quebec, Canada), M.-P. Jacob-Lenet (INSERM, Cardiovascular Structural Diseases, Paris, France), M. Leboyer (University Hospital Centre Henri Mondor, Créteil, France), F.-X. Maquart (University Hospital Centre Reims Biochemistry Laboratory, Reims, France), J.-M. Molina (Saint Louis Hospital, Paris, France), J.-C. Monboisse (University Hospital Centre Reims Biochemistry Laboratory, Reims, France), N. Mazure (Nice, France)

Current Research in Translational Medicine. Cellular and Immune Therapy is a peer-reviewed journal, publishing worlwide clinical and basic research in the field of hematology, immunology, hematopoietic cell transplantation, and cellular and gene therapy. The journal considers for publication English-language editorials, original articles, reviews, and short reports including case-reports. Contributions are intended to draw attention to experimental medicine and translational research. Current Research in Translational Medicine periodically publishes thematic issues and is indexed in all major international databases. 2021 Impact Factor: 4.192. Source: 2021 Journal Citation Reports (Clarivate Analytics, 2022). 4 issues/year. E-journal

Core areas covered in Current Research in Translational Medicine are:

  • Hematology
  • Immunology
  • Hematopoietic Cell Transplantation
  • Cellular and Gene Therapy

Current Research in Translational Medicine. Cellular and Immune Therapy is a peer-reviewed journal, publishing worlwide clinical and basic research in the field of hematology, immunology, hematopoietic cell transplantation, and cellular and gene therapy. The journal considers for publication English-language editorials, original articles, reviews, and short reports including case-reports. Contributions are intended to draw attention to experimental medicine and translational research. Current Research in Translational Medicine periodically publishes thematic issues and is indexed in all major international databases. 2021 Impact Factor: 4.192. Source: 2021 Journal Citation Reports (Clarivate Analytics, 2022). 4 issues/year. E-journal

Core areas covered in Current Research in Translational Medicine are:

  • Hematology
  • Immunology
  • Hematopoietic Cell Transplantation
  • Cellular and Gene Therapy
Leggere il seguito Nascondere

    • 2021 Impact Factor*: 4.192
      *2021 Journal Citation Reports (Clarivate Analytics, 2022)

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.